Low dose estrogen interrupted hormone replacement therapy

Details for Australian Patent Application No. 2005201151 (hide)

Owner Ortho-McNeil Pharmaceutical Inc Jencap Research Ltd

Inventors Ausmanas, Militza K; Casper, Robert F; Shangold, Gary A

Agent Freehills

Pub. Number AU-B-2005201151

Parent 34123

Filing date 17 March 2005

Wipo publication date 21 April 2005

Acceptance publication date 10 January 2008

International Classifications

A61P 5/24 (2006.01) Drugs for disorders of the endocrine system

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

Event Publications

7 April 2005 Complete Application Filed

21 April 2005 Application Open to Public Inspection

  Published as AU-B-2005201151

10 January 2008 Application Accepted

  Published as AU-B-2005201151

8 May 2008 Standard Patent Sealed

21 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005201152-Coating composition of photocatalyst

2005201150-Method and kit for immuno-detecting bacteria in blood and tissues